Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04740697 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study to Evaluate the Impact of the Use of Alternative and Complementary Therapies on Therapeutic Adherence in Patients Treated With taMoxifen for Early Stage Breast Cancer

Study acronym: EUTACAM
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Feb 2026 to Feb 2028v10
  2. 2 versions Re-verified since Apr 8, 2024, no change to tracked fieldsv8-v9
  3. Primary and study completion dates: Feb 2024 to Feb 2026v7
  4. Re-verified, no change to tracked fieldsv6
  5. Primary and study completion dates: Aug 2022 to Feb 2024v5
Show 3 earlier versionsHide 3 earlier versions
  1. Re-verified, no change to tracked fieldsv4
  2. Start date changed from estimate of Feb 2021 to Feb 12, 2021v3
  3. Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a pilot, prospective, interventional, monocentric study designed to evaluate, in a real-life situation, adherence to tamoxifen treatment as a function of the taking of alternative and complementary therapies in patients with localized hormone-dependent breast cancer. 200 patients will be included in the study. Each patient will be followed for one day.
Trial Details
NCT Number NCT04740697
Lead Sponsor Institut Claudius Regaud
Conditions
(from sponsor)		 Breast Cancer
Related terms Breast Neoplasms, Treatment Adherence and Compliance
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov